, Table of Contents
i# i#
Chapter i#1: i#An i#Introduction i#to i#Evidence-Based i#Clinical i#Practice i#Guidelines ........................................ 3
Chapter i#2: i#Pharmacokinetics i#/Chapter3: i#Pharmacodynamics............................................................... 13
Chapter4: i # Pharmacogenetics and i# Pharmacogenomics ........................................................................... 25
e
Chapter i#5: i#Pharmacology i#Across i#the i#Life i#Span .................................................................................. 30
Chapter i#6: i#Drug-Therapy i#Prescribing in i#Special i#Populations .............................................................. 36
e
Chapter i#7: i#Drug i#Development i#and Approval ........................................................................................ 45
e
Chapter i#8-Chapter i#10: i#Foundations i#of i#Prescription i#Writing Chapter i#9: i#ResponsibleControlled-
e
Substance i#Prescribing Chapter i#10: i#Antibiotic i#Stewardship..................................................................... 51
e
Chapter i#11: i#Applied i#Calculations i#for i#Prescribing ............................................................................... 58
Chapter i#12-: i#Promoting Adherence i#With i#Pharmacotherapy i#II: i#System-Specific i#and i#Patient-
e
Focusedi#Prescribing Chapter i#13:i#Pharmacotherapyi#for i#Ear, i#Nose,i#Mouth,i#andThroat i#Conditions i#/Chapter
e
i#14: i#Pharmacotherapy i#for i#Eye i#Conditions............................................................................................. 67
Chapter i#15: i#Pharmacotherapy i#for i#Skin i#Conditions .............................................................................. 74
Chapter i#16: i#Pharmacotherapy i#for i#Neurologic i#Conditions ................................................................... 81
Chapter i# 17: i#Pharmacotherapy i#for i#Cardiovascular i# Conditions ............................................................ 94
Chapter i# 18: i#Pharmacotherapy i#for i#Respiratory i#Conditions................................................................. 106
Chapter i#19: i#Pharmacotherapy i#for i#Gastrointestinal i#Conditions i#and i#Conditions i#RequiringNutritional i#Support
. ........................................................................................................................................................... 117
Chapter i# 20: i#Pharmacotherapy i#for i# Genitourinary i#Conditions ............................................................. 128
Chapter i#21: i#Pharmacotherapy i#for i#Renal, i#Acid–Base, i#Fluid, i#and i#Electrolyte i#Disorders .................... 133
Chapter i# 22: i#Pharmacotherapy i#for i#Musculoskeletal i#and i#Rheumatologic i#Conditions ........................ 146
Chapter i#23: i#Therapeutic i# Applications i# of i#Immunology i#and i#Vaccines .............................................. 158
Chapter i#24: i#Pharmacotherapy i#for i# Endocrine i#Disorders .................................................................... 163
Chapter i#25: i#Pharmacotherapy i#for i#Hematologic i#Disorders ................................................................. 174
Chapter i#26: i#Hematology/Oncology i#and i#Supportive i#Care i#for i#the i#Nononcologist............................... 190
Chapter i # 27: i#Pharmacotherapy i#Related i#to i#Women’s i#Health i#Conditions ........................................... 196
Chapter i#28: i#Pharmacotherapy i#Related i#to i#Men’s i#Health i#Conditions.................................................. 211
Chapter i#29: i#Pharmacotherapy i#Related toi#Transgender i#Care ................................................................. 217
e
Chapter i#30: i#Antimicrobial i#Pharmacotherapy ...................................................................................... 224
Chapter i# 31: i#Antiretroviral i#Pharmacotherapy ...................................................................................... 235
Chapter i#32: i#Psychopharmacology i#and i#Integrative i#Health: i#Combined i#Treatment i#ofPsychiatric
i#and Neurocog i#nitive i#Conditions ........................................................................................................ 247
e e
Chapter i# 33: i#Pharmacotherapy i#for i#Pain i#Management ......................................................................... 257
Chapter i#34: i#Substance i#Use i#Disorder i#III: i#Health i#Promotion i#and i#Maintenance ................................... 267
Chapter i#35: i#Over-the-Counter i# Medications........................................................................................ 283
Chapter i#36: i#Pharmacotherapy i#for i#Obesity ......................................................................................... 291
,Chapteri#1: i#An i#Introduction to i#Evidence-Based i#Clinical i#Practice i#Guidelines
e
MULTIPLE i#CHOICE
• What i#isi#the i#primary i#purpose i#of i#the i#nursing i#assessment?
A. Identifying i#underlying i#pathologic i#conditions
B. Assisting i# the i#physician in identifying i# medical i # conditions
e e
C. Determining i#the i#patients i#mental i#status
D. Exploring i#patient responses i#to i#health i#problems
e
ANS:i#D
A i#nursing i#assessment i#is done i#to identify i#the i#patients response i#to i#health
e e e
i#probl i#ems. i#During the i#nursing
e i#assessment i#phase,
i#a comprehensive information i#bas i#e i#is i#developed i#through i#a i#physical
e e
i#examination, i#nursing i#history, i#medication i#hi i#story, i#and i#professional
i#observation. i#Identifying i#underlying i#pathologic i#condit i#ions i#and i#assisting
i#the physician in i#identifying i#medical i#conditions i#is i#not i#part i#o i#f i#the
e e
i#nursing i#process. i#Determining i#the i#patients i#mental i#status i#is i#one i#part i#of i#th
i#e i#nursing i#assessment, i#but i#it i#is i#not i#the i#primary i#purpose.
e
DIF: i#Cognitive i#Level:
i#Comprehension i # REF: i#dm 36 i#OBJ:
e e
i#1 i#| i#3 i#TOP: i#Nursing i#Pr i#ocess i#Step:
i#Assessment
MSC: i#NCLEX i#Client i#Needs i#Category: i#Health Promotion i#and i#Maintenance
e
• Whati#isi#the i#basis i#ofi#the NANDAI i#taxonomy?
e
A. Functional i#health i#patterns
B. Human i#response i#patterns
C. Basic i#human needs
e
D. Pathophysiologic i # needs
ANS:i#B
The i#NANDA i#I i # taxonomy i#identifies i#human i#response i#patterns.
e
i#Functional i#components i#of i#health i#patterns i#are i#limited i#to activity, i#fluid
e
i#volume, i#nutrition
, i#self i#care, i#and i#sensory i#perception. i#Basic i#human i#needs i#comprise i#less
i#than i#m i#erely i#health i#patterns. i#Pathophysiologic i#needs i#are i#not i#part of e
i#the scope of i#N i#ANDAi#I.
e e
, DIF: i#Cognitive i#Level: i#Knowledge i#REF:
pp.i#37-38 i#OBJ: i#5 i#TOP:
Nursing i#Process i#Step: i#Diagnosis
MSC: i#NCLEX i#Client i#Needs i#Category: i#Physiological i#Integrity
• Which i#task i#is i#included i#in the i#assessment i#step i#of i#the i#nursing i# process?
e e
A. Establishing i#patient i#goals/outcomes
B. Implementing i#the i#nursing i#care i#plan i#(NCP)
C. Measuring goal/outcome i#achievement
e
D. Collecting i#and i#communicating i#data
ANS: D e
Data i#are i#collected i#and i#communicated i#in the i#assessment i#phase i#of i#the
e
i#nursing i # process. i#Establishing i#goals i#is the i#function of i#planning.
e e e
Implementing the i#NCP i#is i#the i#function i#of i#implementation. i#Measuring
e
i#outcom i#e i#achievement i#is the i#function of i#evaluation.
e e
DIF: i#Cognitive i#Level:
i#Comprehension i#REF: i#dm i#36 i#OBJ: i#2
i#| i#3 i#TOP: i#Nursing i#Pr i#ocess i#Step:
i#Assessment
MSC: i#NCLEX i#Client i#Needs i#Category: i#Health i#Promotion i#and i#Maintenance
e
• Which i#statement i#regarding i#nursing i#diagnoses i# is i# accurate? e
a. Nursing i#diagnoses i#remaini#the i#same i#fori#as i#long as i#the i#disease i#is i#present.
e
b. Nursing i#diagnoses i#are i#written i#to i#identify i#disease i#states.
c. Nursing i#diagnoses i#describe i#patient i#problems that i#nurses i # treat.
e
d. Nursing i#diagnoses i#identify i#causes i#related to illness.
e e e
ANS:i#C
Diagnostic i#statements i#identify i#problems i#a i#nurse is i#independently i#able
e
i#to trea i#t i#within i#the i#scope i#of i#professional i#practice. i#Nursing i#diagnoses
e
i#vary i#with i#the i#c i#hanging i#condition i#of i#the i#patient. i#The i#response i#patterns
i#are i#unique i#to i#the pati e i#ent i#and are i#not disease i#specific.
e e i#Nursing
i#diagnoses i#describe i#the i#patients hum i#an i#response i#pattern.
e
DIF: i#Cognitive i#Level: i#Comprehension
i# i#
Chapter i#1: i#An i#Introduction i#to i#Evidence-Based i#Clinical i#Practice i#Guidelines ........................................ 3
Chapter i#2: i#Pharmacokinetics i#/Chapter3: i#Pharmacodynamics............................................................... 13
Chapter4: i # Pharmacogenetics and i# Pharmacogenomics ........................................................................... 25
e
Chapter i#5: i#Pharmacology i#Across i#the i#Life i#Span .................................................................................. 30
Chapter i#6: i#Drug-Therapy i#Prescribing in i#Special i#Populations .............................................................. 36
e
Chapter i#7: i#Drug i#Development i#and Approval ........................................................................................ 45
e
Chapter i#8-Chapter i#10: i#Foundations i#of i#Prescription i#Writing Chapter i#9: i#ResponsibleControlled-
e
Substance i#Prescribing Chapter i#10: i#Antibiotic i#Stewardship..................................................................... 51
e
Chapter i#11: i#Applied i#Calculations i#for i#Prescribing ............................................................................... 58
Chapter i#12-: i#Promoting Adherence i#With i#Pharmacotherapy i#II: i#System-Specific i#and i#Patient-
e
Focusedi#Prescribing Chapter i#13:i#Pharmacotherapyi#for i#Ear, i#Nose,i#Mouth,i#andThroat i#Conditions i#/Chapter
e
i#14: i#Pharmacotherapy i#for i#Eye i#Conditions............................................................................................. 67
Chapter i#15: i#Pharmacotherapy i#for i#Skin i#Conditions .............................................................................. 74
Chapter i#16: i#Pharmacotherapy i#for i#Neurologic i#Conditions ................................................................... 81
Chapter i# 17: i#Pharmacotherapy i#for i#Cardiovascular i# Conditions ............................................................ 94
Chapter i# 18: i#Pharmacotherapy i#for i#Respiratory i#Conditions................................................................. 106
Chapter i#19: i#Pharmacotherapy i#for i#Gastrointestinal i#Conditions i#and i#Conditions i#RequiringNutritional i#Support
. ........................................................................................................................................................... 117
Chapter i# 20: i#Pharmacotherapy i#for i# Genitourinary i#Conditions ............................................................. 128
Chapter i#21: i#Pharmacotherapy i#for i#Renal, i#Acid–Base, i#Fluid, i#and i#Electrolyte i#Disorders .................... 133
Chapter i# 22: i#Pharmacotherapy i#for i#Musculoskeletal i#and i#Rheumatologic i#Conditions ........................ 146
Chapter i#23: i#Therapeutic i# Applications i# of i#Immunology i#and i#Vaccines .............................................. 158
Chapter i#24: i#Pharmacotherapy i#for i# Endocrine i#Disorders .................................................................... 163
Chapter i#25: i#Pharmacotherapy i#for i#Hematologic i#Disorders ................................................................. 174
Chapter i#26: i#Hematology/Oncology i#and i#Supportive i#Care i#for i#the i#Nononcologist............................... 190
Chapter i # 27: i#Pharmacotherapy i#Related i#to i#Women’s i#Health i#Conditions ........................................... 196
Chapter i#28: i#Pharmacotherapy i#Related i#to i#Men’s i#Health i#Conditions.................................................. 211
Chapter i#29: i#Pharmacotherapy i#Related toi#Transgender i#Care ................................................................. 217
e
Chapter i#30: i#Antimicrobial i#Pharmacotherapy ...................................................................................... 224
Chapter i# 31: i#Antiretroviral i#Pharmacotherapy ...................................................................................... 235
Chapter i#32: i#Psychopharmacology i#and i#Integrative i#Health: i#Combined i#Treatment i#ofPsychiatric
i#and Neurocog i#nitive i#Conditions ........................................................................................................ 247
e e
Chapter i# 33: i#Pharmacotherapy i#for i#Pain i#Management ......................................................................... 257
Chapter i#34: i#Substance i#Use i#Disorder i#III: i#Health i#Promotion i#and i#Maintenance ................................... 267
Chapter i#35: i#Over-the-Counter i# Medications........................................................................................ 283
Chapter i#36: i#Pharmacotherapy i#for i#Obesity ......................................................................................... 291
,Chapteri#1: i#An i#Introduction to i#Evidence-Based i#Clinical i#Practice i#Guidelines
e
MULTIPLE i#CHOICE
• What i#isi#the i#primary i#purpose i#of i#the i#nursing i#assessment?
A. Identifying i#underlying i#pathologic i#conditions
B. Assisting i# the i#physician in identifying i# medical i # conditions
e e
C. Determining i#the i#patients i#mental i#status
D. Exploring i#patient responses i#to i#health i#problems
e
ANS:i#D
A i#nursing i#assessment i#is done i#to identify i#the i#patients response i#to i#health
e e e
i#probl i#ems. i#During the i#nursing
e i#assessment i#phase,
i#a comprehensive information i#bas i#e i#is i#developed i#through i#a i#physical
e e
i#examination, i#nursing i#history, i#medication i#hi i#story, i#and i#professional
i#observation. i#Identifying i#underlying i#pathologic i#condit i#ions i#and i#assisting
i#the physician in i#identifying i#medical i#conditions i#is i#not i#part i#o i#f i#the
e e
i#nursing i#process. i#Determining i#the i#patients i#mental i#status i#is i#one i#part i#of i#th
i#e i#nursing i#assessment, i#but i#it i#is i#not i#the i#primary i#purpose.
e
DIF: i#Cognitive i#Level:
i#Comprehension i # REF: i#dm 36 i#OBJ:
e e
i#1 i#| i#3 i#TOP: i#Nursing i#Pr i#ocess i#Step:
i#Assessment
MSC: i#NCLEX i#Client i#Needs i#Category: i#Health Promotion i#and i#Maintenance
e
• Whati#isi#the i#basis i#ofi#the NANDAI i#taxonomy?
e
A. Functional i#health i#patterns
B. Human i#response i#patterns
C. Basic i#human needs
e
D. Pathophysiologic i # needs
ANS:i#B
The i#NANDA i#I i # taxonomy i#identifies i#human i#response i#patterns.
e
i#Functional i#components i#of i#health i#patterns i#are i#limited i#to activity, i#fluid
e
i#volume, i#nutrition
, i#self i#care, i#and i#sensory i#perception. i#Basic i#human i#needs i#comprise i#less
i#than i#m i#erely i#health i#patterns. i#Pathophysiologic i#needs i#are i#not i#part of e
i#the scope of i#N i#ANDAi#I.
e e
, DIF: i#Cognitive i#Level: i#Knowledge i#REF:
pp.i#37-38 i#OBJ: i#5 i#TOP:
Nursing i#Process i#Step: i#Diagnosis
MSC: i#NCLEX i#Client i#Needs i#Category: i#Physiological i#Integrity
• Which i#task i#is i#included i#in the i#assessment i#step i#of i#the i#nursing i# process?
e e
A. Establishing i#patient i#goals/outcomes
B. Implementing i#the i#nursing i#care i#plan i#(NCP)
C. Measuring goal/outcome i#achievement
e
D. Collecting i#and i#communicating i#data
ANS: D e
Data i#are i#collected i#and i#communicated i#in the i#assessment i#phase i#of i#the
e
i#nursing i # process. i#Establishing i#goals i#is the i#function of i#planning.
e e e
Implementing the i#NCP i#is i#the i#function i#of i#implementation. i#Measuring
e
i#outcom i#e i#achievement i#is the i#function of i#evaluation.
e e
DIF: i#Cognitive i#Level:
i#Comprehension i#REF: i#dm i#36 i#OBJ: i#2
i#| i#3 i#TOP: i#Nursing i#Pr i#ocess i#Step:
i#Assessment
MSC: i#NCLEX i#Client i#Needs i#Category: i#Health i#Promotion i#and i#Maintenance
e
• Which i#statement i#regarding i#nursing i#diagnoses i# is i# accurate? e
a. Nursing i#diagnoses i#remaini#the i#same i#fori#as i#long as i#the i#disease i#is i#present.
e
b. Nursing i#diagnoses i#are i#written i#to i#identify i#disease i#states.
c. Nursing i#diagnoses i#describe i#patient i#problems that i#nurses i # treat.
e
d. Nursing i#diagnoses i#identify i#causes i#related to illness.
e e e
ANS:i#C
Diagnostic i#statements i#identify i#problems i#a i#nurse is i#independently i#able
e
i#to trea i#t i#within i#the i#scope i#of i#professional i#practice. i#Nursing i#diagnoses
e
i#vary i#with i#the i#c i#hanging i#condition i#of i#the i#patient. i#The i#response i#patterns
i#are i#unique i#to i#the pati e i#ent i#and are i#not disease i#specific.
e e i#Nursing
i#diagnoses i#describe i#the i#patients hum i#an i#response i#pattern.
e
DIF: i#Cognitive i#Level: i#Comprehension
